ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Study: Testosterone Gels and Serum Levels
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="CoastWatcher" data-source="post: 84367" data-attributes="member: 2624"><p>More and more men come to realize that certain topical testosterone applications fail many patients. A recent Boston-based study looked at why hypogonadal men treated with testosterone <em>gels </em>posted such a substantial variability in the serum levels they obtained from this mode of TRT. Specifically, the researchers hoped to determine whether polymorphisms in genes encoding testosterone enzyme could explain the variation.</p><p></p><ul> <li data-xf-list-type="ul">Data from three randomized trials (detailed below) was used retrospectively.</li> <li data-xf-list-type="ul">All men were treated with 1% transdermal testosterone gel.</li> <li data-xf-list-type="ul">Serum levels were tested two to four weeks after multiple dose adjustments.</li> </ul><p></p><p>In all three studies there was substantial variation in testosterone levels. The authors of the study concluded that baseline characteristics (age, height, weight, baseline testosterone, SHBG, hematocrit, and creatinine) "accounted for only a small fraction of the variance."</p><p></p><ul> <li data-xf-list-type="ul">In a study assessing testosterone's use on pain perception, 47% of men failed to raise their testosterone above the 400ng/dL level. Six percent of study participants raised their serum levels to the 1000ng/dL mark.</li> <li data-xf-list-type="ul">A study dealing with testosterone's impact on atherosclerosis indicated that 38% of men failed to raise the level above the same marker (400ng/dL). Only eight percent of men in this study achieved a serum level of 1000ng/dL.</li> <li data-xf-list-type="ul">A study of testosterone on mobility and older men indicated that 9% of participants failed to raise testosterone above 400ng/dL. This study produced the largest number of men who raised testosterone above 1000ngdL - 30%.</li> </ul><p></p><p>What has been observed clinically for some time has been confirmed: many men do not respond to testosterone gels. The authors conclude that the role of SHBG and AKR3C1 polymorphisms are implicated in this phenomenon and call for more testing to see if that can be confirmed.</p><p></p><p><em>Contributors to the substantial variation in on-treatment testosterone levels in men receiving transdermal testosterone gels in randomized trials Andrology, 5 October 2017</em></p><p><em></em></p><p><em></em><a href="http://onlinelibrary.wiley.com/doi/10.1111/andr.12428/full" target="_blank">http://onlinelibrary.wiley.com/doi/10.1111/andr.12428/full</a></p></blockquote><p></p>
[QUOTE="CoastWatcher, post: 84367, member: 2624"] More and more men come to realize that certain topical testosterone applications fail many patients. A recent Boston-based study looked at why hypogonadal men treated with testosterone [I]gels [/I]posted such a substantial variability in the serum levels they obtained from this mode of TRT. Specifically, the researchers hoped to determine whether polymorphisms in genes encoding testosterone enzyme could explain the variation. [LIST] [*]Data from three randomized trials (detailed below) was used retrospectively. [*]All men were treated with 1% transdermal testosterone gel. [*]Serum levels were tested two to four weeks after multiple dose adjustments. [/LIST] In all three studies there was substantial variation in testosterone levels. The authors of the study concluded that baseline characteristics (age, height, weight, baseline testosterone, SHBG, hematocrit, and creatinine) "accounted for only a small fraction of the variance." [LIST] [*]In a study assessing testosterone's use on pain perception, 47% of men failed to raise their testosterone above the 400ng/dL level. Six percent of study participants raised their serum levels to the 1000ng/dL mark. [*]A study dealing with testosterone's impact on atherosclerosis indicated that 38% of men failed to raise the level above the same marker (400ng/dL). Only eight percent of men in this study achieved a serum level of 1000ng/dL. [*]A study of testosterone on mobility and older men indicated that 9% of participants failed to raise testosterone above 400ng/dL. This study produced the largest number of men who raised testosterone above 1000ngdL - 30%. [/LIST] What has been observed clinically for some time has been confirmed: many men do not respond to testosterone gels. The authors conclude that the role of SHBG and AKR3C1 polymorphisms are implicated in this phenomenon and call for more testing to see if that can be confirmed. [I]Contributors to the substantial variation in on-treatment testosterone levels in men receiving transdermal testosterone gels in randomized trials Andrology, 5 October 2017 [/I][URL]http://onlinelibrary.wiley.com/doi/10.1111/andr.12428/full[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Study: Testosterone Gels and Serum Levels
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top